Informations générales (source: ClinicalTrials.gov)

NCT01101295 Statut inconnu
The ITP-RITUX Cohort: An Observational Study on Rituximab Off-label Use for Immune ThrombocytoPenia.
Observational
  • Purpura
  • Purpura thrombopénique
  • Thrombopénie
  • Purpura thrombopénique idiopathique
Henri Mondor University Hospital (Voir sur ClinicalTrials)
avril 2010
avril 2017
13 septembre 2025
The primary purpose of the study is to describe by a prospective observational study the serious adverse events occurring in patients treated off-label by rituximab for Immune Thrombocytopenia.
 Voir le détail

Etablissements

Les établissements d'Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données
CENTRE IMAGERIE DE MARNE LA VALLEE Mehdi KHELLAF, MD En recrutement IDF Contact (sur clinicalTrials)
HOPITAL PRIVE DE MARNE LA VALLEE Mehdi KHELLAF, MD En recrutement IDF Contact (sur clinicalTrials)

Critères

Tous
Inclusion Criteria:

- ITP diagnosis according to the American Society of Hematology society

- Secondary ITP if the underlying disease is an autoimmune disease(Lupus,Sjogren..)


- Previous treatment by rituximab

- Secondary ITP associated to a hematologic disease (Chronic Lymphocytic Leukemia,
Hodgkin Disease...)

- Secondary ITP associated to a chronic infectious disease (Hepatitis B, C, HIV)